Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Chemotherapy in Participants With Advanced Solid Tumors
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Pancreatic Cancer|Non-small Cell Lung Cancer|Esophagogastric Cancer|Colorectal Cancer|Breast Cancer
Interventions: DRUG: Andecaliximab|DRUG: Gemcitabine|DRUG: Nab-paclitaxel|DRUG: Carboplatin|DRUG: Pemetrexed|DRUG: Leucovorin|DRUG: Oxaliplatin|DRUG: 5-FU|DRUG: Bevacizumab|DRUG: Irinotecan|DRUG: Paclitaxel
Sponsor: Gilead Sciences